|
Press Releases |
|
|
|
Thursday, May 2, 2019 |
|
雅各臣公布盈喜 |
从事非专利药及品牌药品研发、生产、市场推广及销售的领先企业─ 雅各臣科研制药有限公司(「雅各臣」或「集团」;股份代号:2633)今天公布盈喜预告,就集团截至二零一九年三月三十一日止财政年度的未经审核综合管理财务报表之初步评估,预期集团之公司股东应占综合溢利较二零一八年三月三十一日止财政年度增加超过20%。 more info >> |
|
雅各臣公布盈喜 |
從事非專利藥及品牌藥品研發、生產、市場推廣及銷售的領先企業 ─ 雅各臣科研製藥有限公司(「雅各臣」或「集團」;股份代號:2633)今天公佈盈喜預告,就集團截至二零一九年三月三十一日止財政年度的未經審核綜合管理財務報表之初步評估,預期集團之公司股東應佔綜合溢利較二零一八年三月三十一日止財政年度增加超過20%。 more info >> |
|
Tuesday, December 13, 2016 |
|
雅各臣公佈完成收購「何濟公」之100%權益 |
從事非專利藥及品牌藥品研發、生產、市場推廣及銷售的領先企業—雅各臣科研製藥有限公司(「雅各臣」或「集團」;股份代號:2633)今天宣佈完成收購目標集團(由「嘉倫藥業有限公司」、「永生藥業有限公司」及「香港何濟公藥廠有限公司」組成),該目標集團擁有傳統居家品牌「何濟公」之100%權益,總代價為568,000,000港元。 more info >> |
|
Thursday, May 2, 2019 |
|
Jacobson Pharma Issues Positive Profit Alert |
Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company"; Stock Code: 2633), a leading company engaging in the research, development, production, marketing and sale of generic drugs and proprietary medicines, has today announced a positive profit alert. more info >> |
|
Wednesday, November 21, 2018 |
|
雅各臣公布二零一九财年中期业绩 |
从事非专利药及品牌药品研发、生产、市场推广及销售的领先企业─雅各臣科研制药有限公司(「雅各臣」或「集团」;股份代号:2633)今天公布公司及其附属公司(统称「集团」)于截至二零一八年九月三十日止六个月(「报告期」)的未经审核中期业绩。 more info >> |
|
雅各臣公佈二零一九財年中期業績 |
從事非專利藥及品牌藥品研發、生產、市場推廣及銷售的領先企業─雅各臣科研製藥有限公司(「雅各臣」或「集團」;股份代號:2633)今天公佈公司及其附屬公司(統稱「集團」)於截至二零一八年九月三十日止六個月(「報告期」)的未經審核中期業績。 more info >> |
|
Jacobson Pharma Announces FY2019 Interim Results |
Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company"; Stock Code: 2633), a leading company engaged in the research, development, production, marketing and sale of generic drugs and proprietary medicines, today announced its unaudited interim results of the Company and its subsidiaries (collectively the "Group") for the six months ended 30 September 2018 (the "reporting period"). more info >> |
|
Monday, June 25, 2018 |
|
Jacobson Pharma Announces 2018 Annual Results |
Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Group"; Stock Code: 2633), a leading company engaged in the research, development, production, marketing and sale of generic drugs and proprietary medicines, today announced its annual results of the Company and its subsidiaries (collectively the "Group") for the year ended 31 March 2018 ("FY2018"). more info >> |
|
雅各臣公布二零一八年全年业绩 |
从事非专利药及品牌药品研发、生产、市场推广及销售的领先企业─雅各臣科研制药有限公司(「雅各臣」或「集团」;股份代号:2633)今天公布公司及其附属公司(统称「集团」)于截至二零一八年三月三十一日止年度(「二零一八财年」)的全年业绩。
more info >> |
|
雅各臣公佈二零一八年全年業績 |
從事非專利藥及品牌藥品研發、生產、市場推廣及銷售的領先企業─雅各臣科研製藥有限公司(「雅各臣」或「集團」;股份代號:2633)今天公佈公司及其附屬公司(統稱「集團」)於截至二零一八年三月三十一日止年度(「二零一八財年」)的全年業績。 more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
SMEIC Proposes to Acquire Shanghai Prime, a Good Catalyst for Building a Development Pattern Featuring Dual-wheel Driver
May 14, 2024 21:54: JST
|
|
|
上海机电拟收购上海集优 利好催化构建双轮驱动发展格局
May 14, 2024 21:01 HKT/SGT
|
|
|
上海機電擬收購上海集優 利好催化構建雙輪驅動發展格局
May 14, 2024 20:59 HKT/SGT
|
|
|
SMEIC Proposal to Acquire Shanghai Prime: A Catalyst for Developing a New Dual-Wheel Driver Pattern
May 14, 2024 20:54 HKT/SGT
|
|
|
Thailand: Ivy launches plum and tamarind juice drinks in SIG XSlimBloc carton packs
May 14, 2024 18:00 HKT/SGT
|
|
|
AsiaMedic partners with Sunway to establish new diagnostic imaging centre
May 14, 2024 18:00 HKT/SGT
|
|
|
雲頂新耀為創新藥物賦能,耐賦康(R)開啟中國腎病治療新時代
May 14, 2024 17:59 HKT/SGT
|
|
|
云顶新耀为创新药物赋能,耐赋康(R)开启中国肾病治疗新时代
May 14, 2024 17:59 HKT/SGT
|
|
|
InfoComm Asia 2024 "Asia's International Pro AV Exhibition" Returns to Thailand
May 14, 2024 16:30 HKT/SGT
|
|
|
3rd Annual Clean Power & New Energy 2024
May 14, 2024 16:03 HKT/SGT
|
|
|
Thailand: Ivy launches plum and tamarind juice drinks in SIG XSlimBloc carton packs
May 14, 2024 16:00 HKT/SGT
|
|
|
Dubai FinTech Summit concludes with over 8,000 visitors from 118 countries
May 14, 2024 14:06 HKT/SGT
|
|
|
DENSO and Certhon Introduce Artemy, A Fully Automated Cherry Truss Tomato Harvesting Robot
May 14, 2024 11:02 JST
|
|
|
Rover Provides Permitting Update on Let's Go Lithium Project, NV, USA
May 14, 2024 07:00 HKT/SGT
|
|
|
Global News and Publishing Platform Gnomi Launches Paid Journalism Program
May 13, 2024 23:15 HKT/SGT
|
|
|
|
More News >> |
|
|
|
|
|